Machine Learning Predicts Response to TNF Inhibitors in Rheumatoid Arthritis: Results on the ESPOIR and ABIRISK Cohorts

Archive ouverte

Bouget, Vincent | Duquesne, Julien | Hassler, Signe | Cournède, Paul-Henry, P.-H. | Fautrel, Bruno | Guillemin, Francis | Pallardy, Marc | Broët, Philippe | Mariette, Xavier | Bitoun, Samuel

Edité par CCSD ; BMJ -

International audience. Objectives Around 30% of patients with rheumatoid arthritis (RA) do not respond to tumour necrosis factor inhibitors (TNFi). We aimed to predict patient response to TNFi using machine learning on simple clinical and biological data. Methods We used data from the RA ESPOIR cohort to train our models. The endpoints were the EULAR response and the change in Disease Activity Score (DAS28). We compared the performances of multiple models (linear regression, random forest, XGBoost and CatBoost) on the training set and cross-validated them using the area under the receiver operating characteristic curve (AUROC) or the mean squared error. The best model was then evaluated on a replication cohort (ABIRISK). Results We included 161 patients from ESPOIR and 118 patients from ABIRISK. The key selected features were DAS28, lymphocytes, ALT (aspartate aminotransferase), neutrophils, age, weight, and smoking status. When predicting EULAR response, CatBoost achieved the best performances of the four tested models. It reached an AUROC of 0.72 (0.68\textendash 0.73) on the train set (ESPOIR). Better results were obtained on the train set when etanercept and monoclonal antibodies were analysed separately. On the test set (ABIRISK), these models respectively achieved on AUROC of 0.70 (0.57\textendash 0.82) and 0.71 (0.55\textendash 0.86). Two decision thresholds were tested. The first prioritised a high confidence in identifying responders and yielded a confidence up to 90% for predicting response. The second prioritised a high confidence in identifying inadequate responders and yielded a confidence up to 70% for predicting non-response. The change in DAS28 was predicted with an average error of 1.1 DAS28 points. Conclusion The machine learning models developed allowed predicting patient response to TNFi exclusively using data available in clinical routine.

Suggestions

Du même auteur

Machine learning identifies a profile of inadequate responder to methotrexate in rheumatoid arthritis

Archive ouverte | Duquesne, Julien | CCSD

International audience. Objectives: Around 30% of patients with RA have an inadequate response to MTX. We aimed to use routine clinical and biological data to build machine learning models predicting EULAR inadequat...

Deep Learning Accurately Predicts Focus Score and Diagnosis of Primary Sjögren Syndrome Using Labial Salivary Gland Biopsies

Archive ouverte | Basseto, Louis | CCSD

International audience. Background/Purpose: Primary Sjögren Syndrome (pSS) diagnosis relies on the weighted sum of three EULAR/ACR 2016 criteria: i) quantification of lymphocyte infiltration in labial salivary gland...

Les anticorps anti-biomédicament sont négativement associés à la réponse au traitement par anti-TNF monoclonaux et anti-IL-6 récepteur dans la polyarthrite rhumatoïde : les résultats de l'étude ABIRISK

Archive ouverte | Bitoun, Samuel | CCSD

International audience

Chargement des enrichissements...